Business
Press Release Jun 10 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 10, 2023, titled "Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 10, 2023, titled \"Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg\". View Attachment","length":353,"tagName":"div"}]